A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study.

Miller, W H

A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Nov 2000 - 1387-9 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0923-7534

10.1023/a:1026579400806 doi


Adult
Aged
Alitretinoin
Antineoplastic Agents--administration & dosage
Carcinoma, Renal Cell--drug therapy
Chemical and Drug Induced Liver Injury--etiology
Combined Modality Therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Synergism
Fatigue--chemically induced
Female
Fever--chemically induced
Humans
Immunologic Factors--administration & dosage
Interferon alpha-2
Interferon-alpha--administration & dosage
Kidney Neoplasms--drug therapy
Male
Middle Aged
Nephrectomy
Pain--chemically induced
Recombinant Proteins
Remission Induction
Treatment Failure
Tretinoin--administration & dosage